
|Videos|February 11, 2022
USP CEO: Why Medicine Quality May Have Been Impacted During the Pandemic
Ronald T. Piervincenzi, CEO of US Pharmacopeia, discusses how drug shortages are related to medicine quality issues.
Advertisement
Pharmacy Times interviewed Ronald T. Piervincenzi, CEO of US Pharmacopeia (USP), on a recent USP survey that showed 9 out of 10 physicians feel their trust in the ability of the US supply chain to deliver safe, quality medicines has eroded.
During the interview, Piervincenzi addressed how drug shortages are related to medicine quality issues and why medicine quality may have been impacted during the COVID-19 pandemic.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
US Measles Cases Climb, Raising Questions About Preparedness and Prevention
2
FDA Awards National Priority Voucher to Teclistamab Plus Daratumumab in Relapsed/Refractory Multiple Myeloma
3
Afamitresgene autoleucel: The First T-Cell Receptor Therapy on the Market
4
FDA Approves Depemokimab as Add-On Maintenance Treatment in Severe Asthma
5












































































































































































































